- Public Inspection: CMS: Medicare Program: Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2026
- Public Inspection: CMS: Medicare Program: Fiscal Year 2026 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements
- CMS: Request for Information; Health Technology Ecosystem
- VA: Staff Sergeant Fox Suicide Prevention Grant Program Funding Opportunity
- State: 60-Day Notice of Proposed Information Collection: J-1 Visa Waiver Recommendation Application
- Public Inspection: CMS: Request for Information: Health Technology Ecosystem
- HHS: Request for Information (RFI): Ensuring Lawful Regulation and Unleashing Innovation To Make American Healthy Again
- VA: Solicitation of Nominations for the Appointment to the Advisory Committee on Tribal and Indian Affairs
- GAO Seeks New Members for Tribal and Indigenous Advisory Council
- VA: Staff Sergeant Fox Suicide Prevention Grant Program Funding Opportunity
- Telehealth Study Recruiting Veterans Now
- USDA Delivers Immediate Relief to Farmers, Ranchers and Rural Communities Impacted by Recent Disasters
- Submit Nominations for Partnership for Quality Measurement (PQM) Committees
- Unleashing Prosperity Through Deregulation of the Medicare Program (Executive Order 14192) - Request for Information
- Dr. Mehmet Oz Shares Vision for CMS
HHS Releases Advisory Opinion Clarifying that 340B Discounts Apply to Contract Pharmacies
The U.S. Department of Health and Human Servies (HHS) Office of the General Counsel released an advisory opinion concluding that drug manufacturers are required to deliver discounts under the 340B Drug Pricing Program to contract pharmacies. The release says, “HHS has become aware of drug manufacturers refusing to provide 340B discounts to covered entities when covered entities order the drugs themselves but then have the drug physically delivered to patients through “contract pharmacies.” Through the new advisory opinion, HHS has clarified that drug manufacturers must provide 340B discounts when a contract pharmacy is acting as an agent of a covered entity, providing services on behalf of the covered entity.” Read the full advisory here.
Introducing Telehealth to Rural and Indigenous Communities
Access the recordings of a five-part Telehealth Virtual Workshop hosted by the Health Resources and Services Administration, in collaboration with the North Dakota Department of Health and Spirit Lake Tribe of North Dakota. Find more information here.
8 Things to Know about the U.S. COVID-19 Vaccination Program
The Centers for Disease Control and Prevention provide answers to some of the most frequently asked questions.
MIPS Participation for Low-Volume Providers
Clinicians are encouraged to go to the Quality Payment Program (QPP) Participation Status Tool to determine if they are required to report into the Merit-based Incentive Program (MIPS) for 2020. Those excluded from MIPS due to low volumes may be eligible to voluntarily report (‘opt-in eligible’). Check out the 2020 MIPS Opt-In Reporting and Election Process Toolkit for more information and visit the Reporting Options Overview Webpage for next steps. Clinicians concerned about the effect of COVID-19 on their 2020 performance data can submit an application for an extreme and uncontrollable exception until February 1 (extended deadline) and cite COVID-19 as the reason for the application. Find more information here.
Medicaid Maternal and Infant Health Initiative
Over the course of 2021, CMS will roll out new technical assistance opportunities for state Medicaid programs and health providers to address maternal and infant health beginning with the Postpartum Care Learning Collaborative webinar series in January. Click here to register for the webinars.
Final Report on Local Use of Rural Hospitals
This final report from Centers for Medicare & Medicaid Services (CMS) builds on the September data brief and explores the extent to which rural Medicare beneficiaries bypass their nearest rural hospital and which hospital services rural beneficiaries most often seek locally and at distant hospitals.
Accountable Health Communities Evaluation Report
This first evaluation report of the CMS Center for Medicare & Medicaid Innovation Accountable Health Communities (AHC) Model focuses on the beneficiaries served in the initial year of the model, which is testing whether addressing health-related social needs can improve health and reduce costs for Medicare and Medicaid beneficiaries.
Price Transparency Compliance
Starting January 2021, the Centers for Medicare & Medicaid Services (CMS) plans to audit a sample of hospitals for compliance with the new price transparency requirements in addition to monitoring complaints. Hospitals may face civil monetary penalties for noncompliance. Read more here.
Rural Value‐Based Care Models: A Summit Findings Report
This Rural Health Value report summarizes themes and recommendations from a two-day summit on how to design and support value-based care models for rural providers. Find more information here.
Comments Requested: Proposed Changes to HIPAA Privacy Rule – February 12
The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services (HHS) seeks comment on proposed changes to the use and disclosure of protected health information (PHI) in the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, which protects the privacy and security of individuals’ medical records and other PHI. Find more information here.